Prediction: Poet’s 220% Surge Sets Up a Potential Correction

POET Technologies (NASDAQ:POET) trades at $13.89 as of June 2, 2026. Our 24/7 Wall St. price target for POET is $10.41 over the next 12 months, implying 25% downside from current levels.

Our recommendation is sell with moderate confidence of 50%, reflecting mixed signals between bullish analyst sentiment and a stretched price after a sharp May spike.

24/7 Wall St. Price Target Summary

Why We Could Be Wrong on POET

Our $10.41 Price Target sits below current levels. POET is one of the most divisive names in AI photonics, and real value could come from $50 million Lumilens purchase order scaling toward its $500 million potential or on-time 800G ramp in Malaysia. Treat our target as one datapoint among many.

From $4 to $14: A Year of Whiplash

POET is up 220.42% over the past year and 119.43% year to date, including a 90.01% surge in the past month. Shares spiked to roughly $15.97 in mid-May 2026 before pulling back to 61% below its 52-week high of $20.81.

The Q1 2026 report showed revenue of $503,389, beating consensus by 44.66%, while EPS came in at -$0.08 against a -$0.04 estimate. 

The Case for $22 and Beyond

Our bull scenario lands at $22.89, a 64.8% return. The thesis rests on Malaysia executing on schedule: high-volume light source production in Q2 2026 and 800G optical engines in Q3 2026, with a target of 30,000+ optical engines shipped this year.

CEO Suresh Venkatesan called Lumilens “an important commercial milestone… supporting frontier AI infrastructure.” POET sits on roughly $430 million in cash, addressing an 800G transceiver market projected at $9.8 billion by 2032.

What Could Drag POET Back to $8

Our bear case lands at $8.33, a 40% drawdown. Revenue still measures in the hundreds of thousands per quarter, and POET carries a $291 million accumulated deficit with a material weakness in internal controls flagged in the 2024 audit. 

Bulls counter that recent EPS misses are distorted by non-cash derivative warrant charges, including a $30.69 million Q4 charge that planned U.S. redomiciliation should largely eliminate. Even so, the gap between current revenue and a $2.4 billion market cap remains wide.

POET Price Prediction 2026-2030

Our 24/7 Wall St. price target is $10.41, recommendation is sell, and confidence is moderate at 50%. The key factor is the gap between POET’s current price and the lone analyst target of $8.20 after a 90% one-month run.

The bull thesis would gain traction if Malaysia hits its Q3 2026 800G milestone and Lumilens converts toward the $500M tier, while the bear thesis strengthens if shipment guidance slips or warrant accounting volatility returns.

These projections assume POET continues executing on its current strategy. Significant upside could come from Lumilens scaling beyond $500 million, while downside risk hinges on Malaysia execution and continued equity dilution.